. 2019 Aug 9;62(5):493–501. doi: 10.3340/jkns.2018.0222
Copyright © 2019 The Korean Neurosurgical Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 3.
Safety of cell reprogramming technologies.